세계의 내시경 역행 췌담관 조영술(ERCP) 시장 보고서(2025년)

Endoscopic Retrograde Cholangiopancreatography (ERCP) Global Market Report 2025

US $ 4,490 ￦ 6,156,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 8,898,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,640,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

내시경 역행 췌담관 조영술(ERCP) 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년에는 8.58%의 연평균 복합 성장률(CAGR)로 26억 달러에 달할 것으로 예측됩니다. 이 기간의 성장 예측은 소화기 질환의 유병률 증가, 암 발병률 증가, 투자 집중도 증가, 췌장관 질환 발생률 증가, 내시경 수요 증가로 인해 발생할 것으로 예측됩니다. 주요 동향으로는 기술 발전, 연구개발을 위한 파트너십, 헬스케어 인프라 확대, 정부의 헬스케어 이니셔티브 증가, 첨단 ERCP 제품 개발 등이 예상됩니다.

위장질환의 유병률 증가는 내시경 역행 췌담관 조영술(ERCP) 시장의 성장을 가속할 것으로 예측됩니다. 이러한 질환은 입, 식도, 위, 위, 장, 직장, 항문 및 간, 담낭, 췌장 등의 부속 기관을 포함한 소화관(GI)에 영향을 미치는 광범위한 질환을 포함합니다. 식습관의 변화, 고령화, 항생제 사용, 생활습관, 환경적 영향 등의 요인으로 인해 이러한 질환의 발생률이 증가하고 있으며, ERCP는 담석, 협착, 종양, 감염과 같은 담관 및 췌장관의 문제를 진단하고 치료하기 위한 저침습적 솔루션입니다. 예를 들어, 미국 암학회는 2024년 1월에 미국에서 약 2만 6,890건의 위암이 새로 발생하여 약 1,880명이 사망할 것으로 추산하고 있습니다. 위장 질환이 보편화됨에 따라 ERCP 시술에 대한 수요는 계속 증가하고 있습니다.

ERCP 시장의 업체들은 진단과 치료를 강화하기 위해 담관경 시스템과 같은 혁신적인 기술을 개발하여 시술법을 발전시키고 있습니다. 2024년 7월, 펜론은 ERCP 시술을 위한 정확한 영상을 제공하는 최첨단 장비인 VedVision 담관경 직접 시각화 시스템인 VedVision 담관경 직접 시각화 시스템을 출시하였습니다. 이 시스템에는 2mm 액세서리 채널과 전용 가이드와이어 채널, 생검 겸자, 결석 제거 바구니, 세포 검사 브러시, 폴립 절제 스네어와 같은 액세서리가 포함되어 진단 및 치료 능력을 향상시킵니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나바이러스 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 내시경 역행 췌담관 조영술(ERCP) PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업 분석
• 세계의 내시경 역행 췌담관 조영술(ERCP) 시장 : 성장률 분석
• 세계의 내시경 역행 췌담관 조영술(ERCP) 시장 실적 : 규모와 성장, 2019-2024
• 세계의 내시경 역행 췌담관 조영술(ERCP) 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 내시경 역행 췌담관 조영술(ERCP) 전체 시장(TAM)

제6장 시장 세분화

• 세계의 내시경 역행 췌담관 조영술(ERCP) 시장 : 제품별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 내시경
• 내시경 치료 기기
• 시각화 시스템
• 에너지 기기
• 세계의 내시경 역행 췌담관 조영술(ERCP) 시장 : 질환 적응증별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 위식도 역류증(GERD)
• 소화기암
• 바렛 식도
• 담관 질환
• 소화성 궤양
• 크론병
• 장 가성 폐색
• 오길비 증후군
• 기타 적응증
• 세계의 내시경 역행 췌담관 조영술(ERCP) 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 담도 괄약근 절개술
• 담도 확장증
• 담관 스텐트 유치술
• 췌괄약근 절개술
• 췌관 확장
• 췌관 스텐트 유치술
• 기타 용도
• 세계의 내시경 역행 췌담관 조영술(ERCP) 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 병원 및 진료소
• 외래수술센터(ASC)
• 기타 최종사용자
• 세계의 내시경 역행 췌담관 조영술(ERCP) 시장 : 내시경별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 연성 내시경
• 반경성 내시경
• 고해상도 내시경
• 세계의 내시경 역행 췌담관 조영술(ERCP) 시장 : 유형별 내시경 치료 기기별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 결석 제거 장비
• 풍선 확장 카테터
• 스텐트
• 생검 겸자
• 세계의 내시경 역행 췌담관 조영술(ERCP) 시장 : 시각화 시스템별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 고해상도 시각화 시스템
• 내시경 영상 시스템
• 비디오 내시경
• 세계의 내시경 역행 췌담관 조영술(ERCP) 시장 : 에너지 기기별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 전기 외과용 기기
• 레이저 디바이스
• 아르곤 플라즈마 응고 시스템

제7장 지역별/국가별 분석

• 세계의 내시경 역행 췌담관 조영술(ERCP) 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 내시경 역행 췌담관 조영술(ERCP) 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 내시경 역행 췌담관 조영술(ERCP) 시장 : 경쟁 구도
• 내시경 역행 췌담관 조영술(ERCP) 시장 : 기업 개요
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업 및 혁신 기업

• B. Braun Melsungen AG
• Olympus Corporation
• Ottomed Endoscopy
• W. L. Gore & Associates Inc.
• Streis plc
• Cook Group
• KARL STORZ SE & Co. KG
• CONMED Corporation
• PENTAX Medical Inc.
• AMBU Inc.
• Samsung Medison Co. Ltd.
• Medi-Globe GmbH
• Telemed System Inc.
• Micro-Tech Endoscopy Inc.
• Hobbs Medical Inc.

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 내시경 역행 췌담관 조영술(ERCP) 시장(2029년) : 새로운 기회를 제공하는 국가
• 내시경 역행 췌담관 조영술(ERCP) 시장(2029년) : 새로운 기회를 제공하는 부문
• 내시경 역행 췌담관 조영술(ERCP) 시장(2029년) : 성장 전략
  • 시장 동향에 근거한 전략
  • 경쟁 전략

제36장 부록

LSH

영문 목차

영문목차

Endoscopic retrograde cholangiopancreatography (ERCP) is a diagnostic and therapeutic medical procedure that integrates endoscopy with X-ray imaging to address conditions affecting the bile ducts, gallbladder, and pancreas. The process involves inserting a flexible, illuminated tube (endoscope) through the mouth into the small intestine, enabling physicians to diagnose and treat issues such as blockages or stones.

The primary products used in ERCP include endoscopes, endotherapy devices, visualization systems, and energy devices. Endoscopes are flexible tubes with a light and camera, allowing healthcare professionals to visualize the internal organs, particularly the digestive tract, during procedures such as ERCP. The procedure addresses various disease indications, including gastroesophageal reflux disease (GERD), gastrointestinal cancer, Barrett's esophagus, bile duct diseases, peptic ulcer disease, Crohn's disease, intestinal pseudo-obstruction, Ogilvie syndrome, and others. ERCP applications include biliary sphincterotomy, biliary dilatation, biliary stenting, pancreatic sphincterotomy, pancreatic duct dilatation, and pancreatic duct stenting. The key end users are hospitals and clinics, ambulatory surgery centers, and other healthcare facilities.

The endoscopic retrograde cholangiopancreatography (ERCP) market research report is one of a series of new reports from The Business Research Company that provides endoscopic retrograde cholangiopancreatography (ERCP) market statistics, including endoscopic retrograde cholangiopancreatography (ERCP) industry global market size, regional shares, competitors with endoscopic retrograde cholangiopancreatography (ERCP) market share, detailed endoscopic retrograde cholangiopancreatography (ERCP) market segments, market trends and opportunities, and any further data you may need to thrive in the endoscopic retrograde cholangiopancreatography (ERCP) industry. This endoscopic retrograde cholangiopancreatography (ERCP) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The endoscopic retrograde cholangiopancreatography (ERCP) market size has grown strongly in recent years. It will grow from $1.72 billion in 2024 to $1.87 billion in 2025 at a compound annual growth rate (CAGR) of 8.87%. The growth during the historical period can be attributed to the increasing prevalence of chronic gastrointestinal diseases, expanded applications of ERCP, a rising incidence of pancreatic cancer, growing government investments, and an increase in medical tourism.

The endoscopic retrograde cholangiopancreatography (ERCP) market size is expected to see strong growth in the next few years. It will grow to $2.60 billion in 2029 at a compound annual growth rate (CAGR) of 8.58%. The growth forecast for this period is driven by the rising prevalence of gastrointestinal conditions, an increasing incidence of cancer, heightened investment focus, a growing occurrence of pancreatic duct conditions, and rising demand for endoscopes. Key trends expected include technological advancements, partnerships for research and development, the expansion of healthcare infrastructure, increased government healthcare initiatives, and the development of advanced ERCP products.

The rising prevalence of gastrointestinal conditions is anticipated to drive the growth of the endoscopic retrograde cholangiopancreatography (ERCP) market. These conditions encompass a wide range of disorders affecting the gastrointestinal (GI) tract, including the mouth, esophagus, stomach, intestines, rectum, anus, and accessory organs such as the liver, gallbladder, and pancreas. Factors such as dietary changes, an aging population, antibiotic use, lifestyle habits, and environmental influences contribute to the increasing incidence of these conditions. ERCP provides a minimally invasive solution for diagnosing and treating bile and pancreatic duct issues, including gallstones, strictures, tumors, and infections. For example, the American Cancer Society estimated in January 2024 that approximately 26,890 new cases of stomach cancer would occur in the United States, with around 10,880 deaths expected. As gastrointestinal conditions become more common, the demand for ERCP procedures continues to grow.

Companies in the ERCP market are advancing procedures by developing innovative technologies, such as cholangioscope systems, for enhanced diagnosis and treatment. These systems provide high-resolution imaging of the bile and pancreatic ducts, improving therapeutic outcomes. In July 2024, Penlon Limited introduced the VedVision Cholangioscope Direct Visualization System, a cutting-edge device offering precise imaging for ERCP procedures. Its features include a 2 mm accessory channel and a dedicated guidewire channel, along with accessories such as biopsy forceps, stone extraction baskets, cytology brushes, and polypectomy snares, enhancing diagnostic and therapeutic capabilities.

In October 2022, OmniVision Technologies Inc., a semiconductor manufacturer based in the United States, collaborated with AdaptivEndo LLC to develop a unified platform for hybrid and single-use endoscopes. This platform is designed for use across various medical specialties, including gastroenterology, hepatology, urology, and gynecology, enabling a more streamlined approach to procedures such as endoscopic retrograde cholangiopancreatography (ERCP) and other endoscopic techniques. AdaptivEndo LLC, also based in the United States, specializes in single-use endoscopy devices that combine the functionalities of endoscopic ultrasound (EUS) and ERCP, offering enhanced versatility and efficiency in clinical practice.

Major players in the endoscopic retrograde cholangiopancreatography (ERCP) market are Medtronic plc, Fujifilm Holdings Corporation, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Ottomed Endoscopy, W. L. Gore & Associates Inc., Streis plc, Cook Group, KARL STORZ SE & Co. KG, CONMED Corporation, PENTAX Medical Inc., AMBU Inc., Samsung Medison Co. Ltd., Medi-Globe GmbH, Telemed System Inc., Micro-Tech Endoscopy Inc., Hobbs Medical Inc., Shaili Endoscopy Pvt. Ltd.

North America was the largest region in the endoscopic retrograde cholangiopancreatography (ERCP) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in endoscopic retrograde cholangiopancreatography (ERCP) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the endoscopic retrograde cholangiopancreatography (ERCP) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The endoscopic retrograde cholangiopancreatography (ERCP) market consists of revenues earned by entities by providing services such as diagnostic services, therapeutic services, post-operative, and follow-up care. The market value includes the value of related goods sold by the service provider or included within the service offering. The endoscopic retrograde cholangiopancreatography (ERCP) market also includes sales of biliary stents, guidewires, and catheters. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Endoscopic Retrograde Cholangiopancreatography (ERCP) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on endoscopic retrograde cholangiopancreatography (ercp) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for endoscopic retrograde cholangiopancreatography (ercp) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The endoscopic retrograde cholangiopancreatography (ercp) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Endoscopes; Endotherapy Devices; Visualization Systems; Energy Devices
• 2) By Disease Indication: Gastroesophageal Reflux Disease (GERD); Gastrointestinal Cancer; Barrett's Esophagus; Bile Duct Diseases; Peptic Ulcer Disease; Crohn's Disease; Intestinal Pseudo-Obstruction; Ogilvie Syndrome; Other Indications
• 3) By Application: Biliary Sphincterotomy; Biliary Dilatation; Biliary Stenting; Pancreatic Sphincterotomy; Pancreatic Duct Dilatation; Pancreatic Duct Stentin
• 4) By End User: Hospitals And Clinics; Ambulatory Surgery Centers; Other End Users
• Subsegments:
• 1) By Endoscopes: Flexible Endoscopes; Semi-Rigid Endoscopes; High-Resolution Endoscopes
• 2) By Endotherapy Devices: Stone Extraction Devices; Balloon Dilatation Catheters; Stents; Biopsy Forceps
• 3) By Visualization Systems: High-Definition Visualization Systems; Endoscopic Imaging Systems; Video Endoscopes
• 4) By Energy Devices: Electrosurgical Devices; Laser Devices; Argon Plasma Coagulation Systems
• Companies Mentioned: Medtronic plc; Fujifilm Holdings Corporation; Siemens Healthineers AG; Stryker Corporation; Boston Scientific Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Characteristics

3. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Trends And Strategies

4. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Growth Analysis And Strategic Analysis Framework

• 5.1. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Growth Rate Analysis
• 5.4. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Total Addressable Market (TAM)

6. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Segmentation

• 6.1. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Endoscopes
• Endotherapy Devices
• Visualization Systems
• Energy Devices
• 6.2. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gastroesophageal Reflux Disease (GERD)
• Gastrointestinal Cancer
• Barrett's Esophagus
• Bile Duct Diseases
• Peptic Ulcer Disease
• Crohn's Disease
• Intestinal Pseudo-Obstruction
• Ogilvie Syndrome
• Other Indications
• 6.3. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biliary Sphincterotomy
• Biliary Dilatation
• Biliary Stenting
• Pancreatic Sphincterotomy
• Pancreatic Duct Dilatation
• Pancreatic Duct Stenting
• Other Applications
• 6.4. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Ambulatory Surgery Centers
• Other End Users
• 6.5. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Sub-Segmentation Of Endoscopes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Flexible Endoscopes
• Semi-Rigid Endoscopes
• High-Resolution Endoscopes
• 6.6. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Sub-Segmentation Of Endotherapy Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stone Extraction Devices
• Balloon Dilatation Catheters
• Stents
• Biopsy Forceps
• 6.7. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Sub-Segmentation Of Visualization Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• High-Definition Visualization Systems
• Endoscopic Imaging Systems
• Video Endoscopes
• 6.8. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Sub-Segmentation Of Energy Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Electrosurgical Devices
• Laser Devices
• Argon Plasma Coagulation Systems

7. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Regional And Country Analysis

• 7.1. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

• 8.1. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

• 9.1. China Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
• 9.2. China Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

• 10.1. India Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

• 11.1. Japan Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
• 11.2. Japan Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

• 12.1. Australia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

• 13.1. Indonesia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

• 14.1. South Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
• 14.2. South Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

• 15.1. Western Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
• 15.2. Western Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

• 16.1. UK Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

• 17.1. Germany Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

• 18.1. France Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

• 19.1. Italy Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

• 20.1. Spain Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

• 21.1. Eastern Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
• 21.2. Eastern Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

• 22.1. Russia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

• 23.1. North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
• 23.2. North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

• 24.1. USA Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
• 24.2. USA Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

• 25.1. Canada Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
• 25.2. Canada Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

• 26.1. South America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
• 26.2. South America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

• 27.1. Brazil Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

• 28.1. Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
• 28.2. Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

• 29.1. Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
• 29.2. Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Competitive Landscape And Company Profiles

• 30.1. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Competitive Landscape
• 30.2. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Company Profiles
  • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Other Major And Innovative Companies

• 31.1. B. Braun Melsungen AG
• 31.2. Olympus Corporation
• 31.3. Ottomed Endoscopy
• 31.4. W. L. Gore & Associates Inc.
• 31.5. Streis plc
• 31.6. Cook Group
• 31.7. KARL STORZ SE & Co. KG
• 31.8. CONMED Corporation
• 31.9. PENTAX Medical Inc.
• 31.10. AMBU Inc.
• 31.11. Samsung Medison Co. Ltd.
• 31.12. Medi-Globe GmbH
• 31.13. Telemed System Inc.
• 31.14. Micro-Tech Endoscopy Inc.
• 31.15. Hobbs Medical Inc.

32. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

34. Recent Developments In The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

35. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market High Potential Countries, Segments and Strategies

• 35.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Endoscopic Retrograde Cholangiopancreatography (ERCP) Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료